Invention Grant
- Patent Title: TLR3 binding agents
-
Application No.: US14403171Application Date: 2013-05-30
-
Publication No.: US09944712B2Publication Date: 2018-04-17
- Inventor: Cécile Bonnafous , Laurent Gauthier , Yannis Morel , Carine Paturel , Ivan Perrot
- Applicant: INNATE PHARMA
- Applicant Address: FR Marseille
- Assignee: Innate Pharma
- Current Assignee: Innate Pharma
- Current Assignee Address: FR Marseille
- Agency: Knobbe Martens Olson & Bear LLP
- International Application: PCT/EP2013/061173 WO 20130530
- International Announcement: WO2013/178736 WO 20131205
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K47/68 ; C07K14/705 ; A61K39/00
Abstract:
Disclosed herein are anti-TLR3 antibodies as well as methods of making and using them. The antibodies are particularly adapted to the treatment of autoimmune or inflammatory diseases using anti-TLR3 antibodies.
Public/Granted literature
- US20150140000A1 TLR3 BINDING AGENTS Public/Granted day:2015-05-21
Information query
